Brief: IGM Biosciences Q3 Net Income USD -61.43 Million
08/11/2024 12:00
Nov 08 (Reuters) - IGM Biosciences Q3 basic EPS USD -1.01. * Q3 operating expenses USD 64.903 million * Q3 pretax profit USD -61.43 million * Q3 collaboration revenue USD 516 thousand * Q3 operating income USD -64.387 million
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary